{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["fbced4f7-d1a5-4ea2-acce-dedd13a1eb43", "Q3", 8511, "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 112847, "GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE)", 2019, "third_quarter", "2019-10-16T10:56:45.187000-04:00", 40000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/fbced4f7-d1a5-4ea2-acce-dedd13a1eb43/\", \"filing_uuid\": \"fbced4f7-d1a5-4ea2-acce-dedd13a1eb43\", \"filing_type\": \"Q3\", \"filing_type_display\": \"3rd Quarter - Report\", \"filing_year\": 2019, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/fbced4f7-d1a5-4ea2-acce-dedd13a1eb43/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"40000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Katina L. Pierce\", \"dt_posted\": \"2019-10-16T10:56:45.187000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"600 Maryland Avenue, SW\", \"registrant_address_2\": \"SUITE 835W\", \"registrant_different_address\": false, \"registrant_city\": \"WASHINGTON\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20024\", \"registrant\": {\"id\": 8511, \"url\": \"https://lda.senate.gov/api/v1/registrants/8511/\", \"house_registrant_id\": 31321, \"name\": \"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.\", \"description\": \"Consultant firm\", \"address_1\": \"600 Maryland Avenue SW\", \"address_2\": \"Suite 220E\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20024\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"KATINA PIERCE\", \"contact_telephone\": \"+1 202-484-1100\", \"dt_updated\": \"2026-01-09T10:20:33.802241-05:00\"}, \"client\": {\"id\": 112847, \"url\": \"https://lda.senate.gov/api/v1/clients/112847/\", \"client_id\": 1005204, \"name\": \"GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE)\", \"general_description\": \"Tuberculosis non-profit drug development company\", \"client_government_entity\": false, \"client_self_select\": null, \"state\": \"NY\", \"state_display\": \"New York\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"NY\", \"ppb_state_display\": \"New York\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2018-03-01\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"US role in TB research and development\\nS 839/HR 3080, The Comprehensive TB Elimination Act\\nS 2438, The End TB Now Act of 2019\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 66841, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ERIN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WILL MORTON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 67930, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"CELIA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HAGAN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"FOR\", \"general_issue_code_display\": \"Foreign Relations\", \"description\": \"USAID tuberculosis program and research for new TB drugs\\nReauthorization of USAID TB program\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 66841, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ERIN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WILL MORTON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 67930, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"CELIA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HAGAN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"BUD\", \"general_issue_code_display\": \"Budget/Appropriations\", \"description\": \"Report language and funding for TB programs at USAID, HHS and DoD\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 66841, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ERIN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WILL MORTON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 67930, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"CELIA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HAGAN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["fbced4f7-d1a5-4ea2-acce-dedd13a1eb43"], "units": {}, "query_ms": 88.71297398582101, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}